FR2634125B1 - Composition pharmaceutique a base de superoxyde dismutase - Google Patents

Composition pharmaceutique a base de superoxyde dismutase

Info

Publication number
FR2634125B1
FR2634125B1 FR8909265A FR8909265A FR2634125B1 FR 2634125 B1 FR2634125 B1 FR 2634125B1 FR 8909265 A FR8909265 A FR 8909265A FR 8909265 A FR8909265 A FR 8909265A FR 2634125 B1 FR2634125 B1 FR 2634125B1
Authority
FR
France
Prior art keywords
pharmaceutical composition
superoxide dismutase
composition based
dismutase
superoxide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR8909265A
Other languages
English (en)
Other versions
FR2634125A1 (fr
Inventor
Michinobu Nakano
Kazuo Katoh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Kayaku Co Ltd
Original Assignee
Nippon Kayaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Kayaku Co Ltd filed Critical Nippon Kayaku Co Ltd
Publication of FR2634125A1 publication Critical patent/FR2634125A1/fr
Application granted granted Critical
Publication of FR2634125B1 publication Critical patent/FR2634125B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/446—Superoxide dismutase (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
FR8909265A 1988-07-12 1989-07-10 Composition pharmaceutique a base de superoxyde dismutase Expired - Lifetime FR2634125B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63171794A JPH0610138B2 (ja) 1988-07-12 1988-07-12 スーパーオキシドディスムターゼ組成物

Publications (2)

Publication Number Publication Date
FR2634125A1 FR2634125A1 (fr) 1990-01-19
FR2634125B1 true FR2634125B1 (fr) 1990-12-21

Family

ID=15929820

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8909265A Expired - Lifetime FR2634125B1 (fr) 1988-07-12 1989-07-10 Composition pharmaceutique a base de superoxyde dismutase

Country Status (10)

Country Link
US (1) US4966774A (fr)
EP (1) EP0355348B2 (fr)
JP (1) JPH0610138B2 (fr)
KR (1) KR900001381A (fr)
AU (1) AU623414B2 (fr)
DE (1) DE68900915D1 (fr)
ES (1) ES2014764A6 (fr)
FR (1) FR2634125B1 (fr)
GB (1) GB2221907B (fr)
IT (1) IT1231473B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0535723A1 (fr) * 1991-08-05 1993-04-07 Sterling Winthrop Inc. Composition tamponnée de PEG-SOD
KR0131678B1 (ko) * 1991-12-09 1998-04-17 유미꾸라 레이이찌 파라티로이드 호르몬류의 안정화 조성물
DE4239877C1 (de) * 1992-11-27 1994-03-17 Boehringer Ingelheim Int Stabilisierte Superoxid-Dismutase (SOD)-Zusammensetzung
KR100383254B1 (ko) * 1995-12-29 2003-08-14 고려화학 주식회사 오닉스 마블 제조용 비닐에스테르 수지의 제조방법
WO2001000230A1 (fr) * 1999-06-24 2001-01-04 Ltt Institute Co., Ltd. Composition medicamenteuse contenant une superoxyde dismutase modifiee par lecithine
CN101500430B (zh) * 2006-08-07 2014-02-19 诺维信公司 用于动物饲料的酶团粒
WO2008017659A1 (fr) 2006-08-07 2008-02-14 Novozymes A/S Granules d'enzyme pour alimentation animale
US8956161B2 (en) 2008-11-04 2015-02-17 Duane C Keller Article and method for controlling oral-originated systemic disease
US8905760B2 (en) * 2008-11-04 2014-12-09 Duane C. Keller Methods and systems for progressively treating and controlling oral periopathogens causing systemic inflammations
US8591229B2 (en) 2010-12-16 2013-11-26 Duane C. Keller Devices and methods for creating a positive pressure environment for treatment of oral biofilms associated with periodontal disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US868566A (en) * 1907-05-21 1907-10-15 Willow Weir Hughes Food-preservative compound.
US3133001A (en) * 1959-11-26 1964-05-12 Muset Pedro Puig Stabilization of enzymes
US4968616A (en) * 1986-05-16 1990-11-06 Masayasu Inoue Superoxide dismutase derivatives, method of producing same and medicinal use of same
JPS63132820A (ja) * 1986-11-22 1988-06-04 Minoru Nakano 口腔用組成物

Also Published As

Publication number Publication date
FR2634125A1 (fr) 1990-01-19
ES2014764A6 (es) 1990-07-16
AU623414B2 (en) 1992-05-14
EP0355348B2 (fr) 1994-06-22
GB2221907B (en) 1991-10-09
AU3788889A (en) 1990-01-18
GB2221907A (en) 1990-02-21
DE68900915D1 (de) 1992-04-09
JPH0610138B2 (ja) 1994-02-09
US4966774A (en) 1990-10-30
KR900001381A (ko) 1990-02-27
IT8948157A0 (it) 1989-07-04
EP0355348A2 (fr) 1990-02-28
EP0355348A3 (en) 1990-03-07
GB8915748D0 (en) 1989-08-31
EP0355348B1 (fr) 1992-03-04
JPH0222233A (ja) 1990-01-25
IT1231473B (it) 1991-12-07

Similar Documents

Publication Publication Date Title
FR2643263B1 (fr) Composition pharmaceutique a base de ranitidine
FR2624732B1 (fr) Formulation pharmaceutique a liberation prolongee
FR2615101B1 (fr) Composition pharmaceutique a base de cefuroxime axetil et sa preparation
MC1782A1 (fr) Preparation pharmaceutique
IT1232677B (it) Composizione farmaceutica contenente ranitidina
FR2636533B1 (fr) Composition pharmaceutique et agent antitumoral a base de limonoides agrumes
DK481989D0 (da) Farmaceutiske formuleringer
DE69029665D1 (de) Arzneimittelbehälter enthaltende Kassette
BR8906708A (pt) Composicao de resina a base de policarbonato
DK673489A (da) Overtrukne klaebetabletter
BE876560A (fr) Composition pharmaceutique a base de triglycerides et d'acylcarnitine et son utilisation
FR2634125B1 (fr) Composition pharmaceutique a base de superoxyde dismutase
FR2638640B1 (fr) Solution pharmaceutique
FR2598617B1 (fr) Composition pharmaceutique
FR2573655B1 (fr) Composition pharmaceutique a base de glycyrrhyzine contre maladies dermiques
FR2589358B1 (fr) Compositions pharmaceutiques a base de diltiazem et d'aspirine
BE856849A (fr) Composition pharmaceutique a base d'organophosphate et de sulfoxyde
DK234489D0 (da) Farmaceutisk praeparat indeholdende et immunosuppressivt middel
FR2551975B1 (fr) Medicament a action antiarythmique a base de lappaconitine
DK205590D0 (da) Farmaceutisk nifedipinholdigt praeparat
IL86672A0 (en) Pharmaceutical composition comprising superoxide dismutase
FR2594334B1 (fr) Composition pharmaceutique injectable a base d'amoxicilline
FR2577802B1 (fr) Compositions pharmaceutiques a base de betaxolol et de nifedipine
IT8721975A0 (it) Composti a base di 7-ossabiciclo(2.2.1)eptano aventi attivita' farmaceutica.
FR2605225B1 (fr) Compositions pharmaceutiques a base d'urokinase

Legal Events

Date Code Title Description
ST Notification of lapse
ST Notification of lapse
ST Notification of lapse